<i>MYD88</i> mutation-positive indolent B-cell lymphoma with CNS involvement: Bing–Neel syndrome mimickers-Reference-Cited by-同舟云学术

<i>MYD88</i> mutation-positive indolent B-cell lymphoma with CNS involvement: Bing–Neel syndrome mimickers

Published:2024 Issue: Volume: Page:
ISSN:1346-4280
Container-title:Journal of Clinical and Experimental Hematopathology
language:en
Short-container-title:JCEH

Author:

Takeda Kenichiro¹,Okazaki Shoichiro¹,Minami Rintaro¹,Ichiki Akihumi²,Yamaga Yusuke¹,Nakajima Kosei³,Kitamura Kunio¹,Karube Kennosuke⁴,Nishiyama Takahiro¹

Affiliation:

1. Division of Hematology, Ichinomiya Municipal Hospital, Ichinomiya, Japan,

2. Department of Hematology, Ichinomiya Nishi Hospital, Ichinomiya, Japan,

3. ivision of Pathology, Ichinomiya Municipal Hospital, Ichinomiya, Japan,

4. Department of Pathology and Laboratory Medicine, Graduate School of Medicine, Nagoya University, Nagoya, Japan

Publisher

Japanese Society for Lymphoreticular Tissue Research

Link

https://www.jstage.jst.go.jp/article/jslrt/advpub/0/advpub_24033/_pdf

Reference15 articles.

1. 1 Varettoni M, Arcaini L, Zibellini S et al. Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom’s macroglobulinemia and related lymphoid neoplasms. Blood. 2013; 121: 2522-2528.

2. 2 Martinez-Lopez A, Curiel-Olmo S, Mollejo M et al. MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma. Am J Surg Pathol. 2015; 39: 644-651.

3. 3 Martinez-Trillos A, Pinyol M, Navarro A et al. Mutations in TLR/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcome. Blood. 2014; 123: 3790-3796.

4. 4 Dogliotti I, Jimenez C, Varettoni M et al. Diagnostics in Waldenstrom’s macroglobulinemia: a consensus statement of the European Consortium for Waldenstrom’s Macroglobulinemia. Leukemia. 2023; 37: 388-395.

5. 5 Rossi D. Role of MYD88 in lymphoplasmacytic lymphoma diagnosis and pathogenesis. Hematology Am Soc Hematol Educ Program. 2014; 2014: 113-118.